ArticleBMC health services research2009
Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study.
Article in BMC health services research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 41 citations in OpenAlex.
- Screening for type 2 diabetes following gestational diabetes: family physician and patient perspectives.Canadian family physician Medecin de famille canadien · 2010Trial
- Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy.Journal of comparative effectiveness research · 2025Article
- Adverse effect of long work hours on incident diabetes in 7065 Ontario workers followed for 12 years.BMJ open diabetes research & care · 2018Article
- Does the evidence support population-wide screening for type 2 diabetes? No.Diabetologia · 2017Article
- Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.S.Journal of general internal medicine · 2015Article
- Observational
- Point-of-Care Hemoglobin A1c Testing: A Budget Impact Analysis.Ontario health technology assessment series · 2014Article
- HbA1c for screening and diagnosis of diabetes mellitus.Endocrine · 2013Review
- Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.BMC public health · 2012Article
- Diabetes screening among immigrants: a population-based urban cohort study.Diabetes care · 2012Article
- Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics.BMC family practice · 2011Article
- Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007.BMC public health · 2011Article
- Investigating concordance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study.BMC health services research · 2010Article
- The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study.BMC public health · 2010Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are concerns that testing for type 2 diabetes is low and many people with diabetes are not diagnosed. We sought to describe the rates of diabetes-related lab testing in Ontario from 1995-2005, among adults without diabetes, and to explore the extent to which the Canadian clinical practice guidelines for screening are being followed.
methodsDescriptive counts of outpatient diabetes laboratory tests performed within Ontario's publicly funded, provincial health insurance program were recorded. The study population was Ontario residents, 20 years and older from 1995 to 2005 (9.3 million people in 2005). The Ontario Diabetes Database, a cumulative registry derived from administrative health records, was used to exclude people who had physician-diagnosed diabetes (n = 839,127 in 2005) from the primary analyses. Diabetes tests included serum blood glucose (SBG), hemoglobin A1c (HbA1c), and oral glucose tolerance tests (OGTT).
resultsIn 2005, 37% of Ontario adults without pre-existing diabetes were tested with an SBG test, a 28% increase from 1995. The age-adjusted proportion of adults without diabetes undergoing a HbA1c test increased from 1.7% in 1995 to 6.0% in 2005. In 2005, a similar number of HbA1c tests were performed for individuals with diabetes (483,746) and without diabetes (496,616) despite large differences in the two groups' denominators. Less than 1% of Ontarians underwent OGTT testing in any year between 1995-2005. Nearly two-thirds of adults age 40 years and over had an SBG test over a 3-year period (April 1, 2002-March 31, 2005), in accordance with the Canadian Diabetes Association recommendations.
conclusionDiabetes testing is common and has increased over the last ten years. Despite its absence in Canada's diabetes screening recommendations, HbA1c testing among individuals without diabetes is increasing rapidly, and OGTT, which is recommended, is rarely performed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.